Conference Coverage (ASCO)

Thalidomide Safe for Use in AIDS-Related Kaposi's Sarcoma

Published in Cancer Weekly, June 29th, 1998

Results of a Phase I trial in Argentina demonstrated that thalidomide (T) is safe for use in AIDS-related Kaposi's sarcoma (KS) patients.

Pedro Politi, representing colleagues from the University of Buenos Aires Medical School, Argentina, and the South American Office for Anticancer Drug Development, Brazil, explained why the group tested T as a therapy for KS at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "Phase I Trial of Thalidomide in AIDS-Related Kaposi's Sarcoma").

"KS is a major cause of morbidity in AIDS patients," stated Politi et al. "Optimal therapy for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-06-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry